DK0544712T3 - Neuraminidase og galactoseoxidase som vaccineadjuvans - Google Patents

Neuraminidase og galactoseoxidase som vaccineadjuvans

Info

Publication number
DK0544712T3
DK0544712T3 DK91914344.6T DK91914344T DK0544712T3 DK 0544712 T3 DK0544712 T3 DK 0544712T3 DK 91914344 T DK91914344 T DK 91914344T DK 0544712 T3 DK0544712 T3 DK 0544712T3
Authority
DK
Denmark
Prior art keywords
neuraminidase
vaccine adjuvant
galactose oxidase
galactose
vaccine
Prior art date
Application number
DK91914344.6T
Other languages
English (en)
Inventor
John Richard Rhodes
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of DK0544712T3 publication Critical patent/DK0544712T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK91914344.6T 1990-08-17 1991-08-16 Neuraminidase og galactoseoxidase som vaccineadjuvans DK0544712T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909018061A GB9018061D0 (en) 1990-08-17 1990-08-17 Compositions for vaccines

Publications (1)

Publication Number Publication Date
DK0544712T3 true DK0544712T3 (da) 1996-03-04

Family

ID=10680805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91914344.6T DK0544712T3 (da) 1990-08-17 1991-08-16 Neuraminidase og galactoseoxidase som vaccineadjuvans

Country Status (10)

Country Link
US (1) US6383498B1 (da)
EP (1) EP0544712B1 (da)
JP (1) JP3051760B2 (da)
AT (1) ATE132375T1 (da)
DE (1) DE69116155T2 (da)
DK (1) DK0544712T3 (da)
ES (1) ES2082221T3 (da)
GB (1) GB9018061D0 (da)
GR (1) GR3019525T3 (da)
WO (1) WO1992003164A1 (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5872151A (en) * 1992-10-01 1999-02-16 Glaxo Wellcome Inc. Immunopotentiatory agents and physiologically acceptable salts thereof
EP0678298A3 (en) * 1992-10-01 1996-05-29 Wellcome Found Use of 4- (2-formyl-3-hydroxyphenoxymethyl) benzoic acid as an immunopotentiating agent.
US5958980A (en) * 1993-08-26 1999-09-28 Glaxo Wellcome, Inc. Immunopotentiatory agent and physiologically acceptable salts thereof
AU2003901008A0 (en) 2003-03-04 2003-03-20 Anadis Ltd Composition for the treatment and prevention of bacterial infections
EP2900259B1 (en) * 2012-09-28 2020-04-15 Kline, Ellis Glycosidase regimen for treatment of infectious disease
US10253294B2 (en) * 2013-12-18 2019-04-09 Julius-Maximilians-Universität Würzburg Galactose oxidase treatment of dendritic cells to improve their immunogenicity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL301025A (da) * 1962-11-28 1900-01-01
DE2620649C3 (de) * 1976-05-11 1980-11-06 Behringwerke Ag, 3550 Marburg Immunologisches Adjuvans

Also Published As

Publication number Publication date
EP0544712B1 (en) 1996-01-03
GR3019525T3 (en) 1996-07-31
ES2082221T3 (es) 1996-03-16
GB9018061D0 (en) 1990-10-03
DE69116155D1 (de) 1996-02-15
JPH06500086A (ja) 1994-01-06
DE69116155T2 (de) 1996-09-05
US6383498B1 (en) 2002-05-07
ATE132375T1 (de) 1996-01-15
JP3051760B2 (ja) 2000-06-12
WO1992003164A1 (en) 1992-03-05
EP0544712A1 (en) 1993-06-09

Similar Documents

Publication Publication Date Title
DK0865297T3 (da) Vaccinesammensætninger til intranasal administration omfattende chitosan og anvendelsen deraf
NO991524L (no) Vaksiner
FI910851A0 (fi) 3-arylkarbonyl-1h-indoler anvaendbara som terapeutiska aemnen.
FI954514A (fi) 3-O-deasyloitua monofosforyylilipidiä A sisältävä rokotekoostumus
FI914004A0 (fi) Epoxifunktionella siloxanhartskopolymerer som loesgoeringsreglerande tillaeggsaemnen.
FI915357A (fi) Optisk bakskiva som foerbinder kretskort.
FI914797A (fi) Maettade hydroxialkylkinolinsyror som leukotrienantagonister.
DK84888A (da) Neisseria gonorrhoea-lectin, anvendeligt som vaccine og diagnostisk markoer, og midler til fremstilling af dette lectin
DE58903654D1 (de) Elastisches lager.
FI912468A (fi) Oxidantkaensliga och -okaensliga aromatiska estrar som inhibitorer foer humant neutrofilelastas.
NO883244D0 (no) Aminoalkylerte hydroksyforbindelser og deres anvendelse som fungicider.
FI915568A0 (fi) Polyamidhartskompositioner foer anvaendning som bindemedel foer laminerande tryckfaergshartser.
DK0544712T3 (da) Neuraminidase og galactoseoxidase som vaccineadjuvans
NO875038D0 (no) Konjugert vaksine.
NO892997D0 (no) Bordetella pertussis vaksine.
FI891543A0 (fi) Kraftoeverfoeringssystem foer transportanordning som griper om dubbelhjul.
NO874114D0 (no) Fluidums trykkregulering og fremgangsmaate.
DE68918189D1 (de) Neisseria-Vakzine.
FI875625A (fi) Roeranslutning som omfattar en muff och en roerkoppling.
NO901169D0 (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.
DK0522059T3 (da) Fastholdelsesindretning og forbindelsesindretning, som indbefatter fastholdelsesindretningen
FI883453A (fi) Bicyklooktanderivat anvaendbara som pesticider och foerfarande foer deras framstaellning.
NO901200L (no) Azol-1-alkanamider som anti-arrytmiske midler og fremstilling derav.
FI910271A0 (fi) Braennanordning som omfattar en cirkulerande flytbaedd.
ATE105483T1 (de) Impfstoff-adjuvans.